Carelabs Co.,Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.
October 14, 2021
Share
Carelabs Co.,Ltd (KOSDAQ:A263700) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million worth of shares pursuant to a contract with NH Investment & Securities Co., Ltd. The purpose of the program is to stabilize stock price and to enhance corporate value. The repurchase program will continue until April 14, 2022.
As of October 13, 2022, the company had no shares in treasury under the dividend capacity and no shares in treasury under other capacities.
Carelabs Co.,Ltd is a Korea-based company mainly engaged in the development and sale of software. Along with subsidiaries, the Company operates its business through three segments. The Healthcare Digital Marketing segment is involved in marketing planning, production and agency business. The Healthcare Media Platform segment is involved in the provision of hospital pharmacy search services and community apps related to beauty care. The products are sold under the name of GOODOC and BABITALK. The Healthcare Solution segment provides customer relationship management (CRM) software, prescription security systems, and pharmacy billing programs. The Company distributes its products within the domestic market and to overseas markets.
CARELABS CO.,LTD 
